SEC Form 4 · accession 0001104659-15-002178
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John M Siebert
Director
Period of report
Dec 16, 2014
Accepted (ET)
Jan 13, 2015 · 6:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 16, 2014 | M | 2,188 | $4.24 | A | 19,563 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy)F1 | $4.24 | Dec 16, 2014 | M | 2,188 | D | — | Oct 14, 2021 | Common Stock | 2,188 | 2,187 | D |
Explanation of responses
- F1The option became exercisable in four equal installments beginning on October 14, 2012.